Kings Point Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-466
Closed -$16K 455
2019
Q4
$16K Hold
466
﹤0.01% 439
2019
Q3
$17K Hold
466
﹤0.01% 417
2019
Q2
$20K Hold
466
﹤0.01% 348
2019
Q1
$20K Sell
466
-1
-0.2% -$45 ﹤0.01% 305
2018
Q4
$21K Hold
467
﹤0.01% 301
2018
Q3
$32K Buy
+467
New +$30.1K 0.01% 283
2018
Q2
Sell
-467
Closed -$22K 356
2018
Q1
$22K Hold
467
﹤0.01% 307
2017
Q4
$22K Hold
467
﹤0.01% 309
2017
Q3
$21K Hold
467
﹤0.01% 294
2017
Q2
$18K Hold
467
﹤0.01% 293
2017
Q1
$18K Hold
467
﹤0.01% 306
2016
Q4
$17K Hold
467
﹤0.01% 277
2016
Q3
$16K Hold
467
﹤0.01% 272
2016
Q2
$15K Hold
467
﹤0.01% 281
2016
Q1
$13K Hold
467
﹤0.01% 300
2015
Q4
$16K Hold
467
﹤0.01% 312
2015
Q3
$13K Hold
467
﹤0.01% 342
2015
Q2
$19K Hold
467
﹤0.01% 297
2015
Q1
$23K Hold
467
0.01% 293
2014
Q4
$21K Buy
+467
New +$18.3K 0.01% 283

Other funds holding AVNS

Kings Point Capital Management's AVNS Position: Q1 2020 in Review

Kings Point Capital Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 466 shares — an estimated $16K sold.

Kings Point Capital Management first reported a position in AVNS in Q4 2014 and held it in 20 quarters. The position peaked at $32K in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Kings Point Capital Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Kings Point Capital Management sold 466 Avanos Medical shares in Q1 2020, an estimated $16K.
  • Kings Point Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 20 quarters.
  • Kings Point Capital Management's Avanos Medical position peaked at $32K in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Kings Point Capital Management's 13F filing for Q1 2020, filed 14 May 2020.